Compare Peptides Side-by-Side | PathToPeptides

Select Compounds

Popular Comparisons

Side-by-Side Comparison

Radar Comparison

Related Tools

Popular Protocols

Frequently Asked Questions

BPC-157 is a pentadecapeptide derived from gastric juice that promotes healing primarily through angiogenesis, VEGF upregulation, and nitric oxide modulation. It has particularly strong evidence for GI tract, tendon, and ligament repair. TB-500 (Thymosin Beta-4) is a 43-amino-acid peptide that promotes healing by upregulating actin, enhancing cell migration, and reducing inflammation. TB-500 has stronger evidence for cardiac tissue repair and wound healing. They work through complementary mechanisms and are frequently combined in research protocols for broader tissue repair coverage.

Semaglutide is a GLP-1 receptor agonist that has demonstrated approximately 15% body weight reduction in clinical trials (STEP program). Tirzepatide is a dual GIP/GLP-1 receptor agonist that targets two incretin pathways simultaneously, achieving up to 22.5% weight loss in the SURMOUNT trials. Both are administered via weekly subcutaneous injection and share similar GI side effects (nausea, constipation). Tirzepatide may offer superior glycemic control due to its dual mechanism, while semaglutide has a longer track record and more post-market safety data as an FDA-approved medication.

Effectiveness depends on your specific goals and tolerance for side effects. CJC-1295 with DAC provides sustained GH elevation over days and is convenient with twice-weekly dosing, but produces less physiological pulsatile release. Ipamorelin is considered the cleanest GHRP with minimal cortisol and prolactin elevation. The combination of CJC-1295 (no DAC) plus Ipamorelin is widely regarded as the most effective GH peptide stack, producing synergistic GH pulses that closely mimic natural secretion patterns. Tesamorelin is the only FDA-approved GHRH analog and has the strongest clinical evidence for visceral fat reduction.

Related Tools & Resources